Renalis

Chicago, United States Founded: 2019 • Age: 7 yrs
Provider of solutions for pelvic health

About Renalis

Renalis is a Healthcare company based in Chicago (United States) founded in 2019 by Missy Lavender, Brandon Chen, and Elizabeth Wood. It operates as a provider of solutions for pelvic health. Renalis has raised $944 thousand across 7 funding rounds from investors including HHS, Gener8tor and JumpStart Ventures. Renalis has completed 1 acquisition, including Vesica. Its chief executive is Missy Lavender. Renalis offers products and services including CeCe. Its focus areas include HealthTech, Disease Self Management, Women Health and Therapy. Its competitors include Keleya, Every Mother, Iron Kegel, Liv Labs and eContinence and 1 more; 4 of its 6 listed competitors have raised funding.

Company details

Renalis was founded in 2019 and is based in Chicago, United States. A platform is operated to deliver solutions in the pelvic health sector, focusing on management of related conditions. Experiences and outcomes for affected individuals are improved through targeted tools and approaches. Key challenges in pelvic health care, such as diagnosis and treatment efficiency, are addressed across operations.

  • Headquarters Chicago, United States
  • Founders Missy Lavender, Brandon Chen, Elizabeth Wood
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website renalis.health
  • Social LinkedIn X Facebook Instagram
Key Metrics
  • Total Equity Funding
    $944K (USD)

    in 7 rounds

  • Latest Funding Round
    $306.97K (USD), Grant

    Sep 2024

  • Investors
    HHS

    & 4 more

  • Investments & Acquisitions

Products & Services of Renalis

Renalis offers a comprehensive portfolio of products and services, including CeCe.

CeCe
Digital Therapeutic

Mobile app providing behavioral therapy for overactive bladder symptoms.

Funding Insights of Renalis

Renalis has successfully raised a total of $944K across 7 strategic funding rounds. The most recent funding activity was a Grant round of $306.97 thousand completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $944,000
  • Total Rounds 7
  • Last Round Grant β€” $306,968
  • First Round $231,368

    (Sep 2019)

  • Investors Count 5

All 7 funding rounds of Renalis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2024$306,968Grant––
Aug 2023$25,000Debt – Conventional––
–
Jun 2022$100,000Seed–Gener8tor
–
Sep 2021$824,000Seed–Jumpstart Ventures, Collab Fund
–
Sep 2020–Seed––
Feb 2020$20,000Seed––
–
Sep 2019$231,368Grant––
Valuation history

5 investors in total: 5 institutional.

Investors in Renalis

Renalis has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Gener8tor and JumpStart Ventures.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Startups are accelerated via a 12-week program with funding support.
2012gener8tor.comMadison, United States
Venture capital funding is provided to tech startups by JumpStart Ventures.
–jumpstart.vcCleveland, United States
Private equity firm investing in multiple sectors
–collabfund.comNew York, United States
Entrepreneurship support, ecosystem strengthening, and impact investing services are offered by Village Capital.
–vilcap.com-
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for Renalis

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Renalis

17 people are tracked at Renalis (8 in leadership, 9 in board & advisors).

NameRoleGroup
Missy Lavender
Founder & CEOLeadership
Brandon Chen
Co-FounderLeadership
Elizabeth Wood
Co-FounderLeadership
Yufan Brandon Chen
Chief Medical Officer & Co-founderLeadership
Anna Baccellieri, PhD, MPA
Director Of Qualitative Research & Co-investigatorLeadership
Yufan Brandon Chen, MD, FACOG FPMRS
Co-Founder, Chief Medical OfficerLeadership
Fares Bouchedid
Chief Technology Officer (CTO)Leadership
Jim Anfield
Chief Privacy OfficerLeadership
Tamara Bavendam
AdvisorBoard & advisors
Arthur Hiller
AdvisorBoard & advisors
Kathe Wallace
AdvisorBoard & advisors
Elizabeth Goettman Christopher
AdvisorBoard & advisors
Tarah Knaresboro
AdvisorBoard & advisors
Joseph Dangelmaier
AdvisorBoard & advisors
Laurence Birch
AdvisorBoard & advisors
Michael Seggev
AdvisorBoard & advisors
Leslie Saltzstein Wooldridge
AdvisorBoard & advisors
Premium access

Complete people profiles for Renalis

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Renalis

Renalis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Vesica.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Urinating habits are tracked and monitored via a mobile application.
vesicaapp.com–2017Dec 2020β€’β€’β€’β€’
Premium access

Complete acquisition details for Renalis

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Renalis

4 dated milestones of Renalis across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Renalis is founded.
  2. Funding First funding round of $231K.
  3. Acquisition Acquires Vesica.
  4. Funding Latest funding round, Grant, of $307K.

Competitors of Renalis

Renalis has 6 listed competitors in our database, 4 of them funded. They include Keleya, Every Mother, Iron Kegel, Liv Labs and eContinence, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
keleya.de2017Hamburg, Germany$3.48M18
App offering exercise and yoga plans for pregnant women
every-mother.com2017Brooklyn, United States$1.5M–
Pregnancy exercises are delivered via an online platform.
ironkegel.pl2021Wrocaw, Poland––
App for Kegel muscle training to improve men's sexual health and posture.
livlabsfitness.com2017Wilmette, United States$125,0003
Provider of personalized training classes and pelvic floor exercises
econtinence.app2021Ostersund, Sweden––
App-based program for treating women's urinary incontinence via exercises, education, and tracking tools.
b-wom.com2015Barcelona, Spain$1.08M–
Develops a mobile app providing guided exercises to strengthen the pelvic area for improved health.
Premium access

Detailed competitors of Renalis

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Health Monitoring & Wearables

10 companies that operate in the same segment as Renalis (Health Monitoring & Wearables), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Smart fitness equipment and streaming platforms are provided.
2011New York, New York, United StatesUSD 995.53 MUSD 2.45 B2,894
Connected devices for health, sleep, and activity monitoring are developed.
2008Moulineaux, Seine-maritime, FranceUSD 93.83 M––
Internet first brand offering wearable breast pumps
2013London, England, United KingdomUSD 157.63 M––
Metabolic health is tracked via devices and fitness platforms.
2019Bengaluru, Karnataka, IndiaUSD 163.28 MUSD 65.48 M274
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013Oulu, North Ostrobothnia, FinlandUSD 1.32 BUSD 398.5 M1,632
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
AI-based mobile app tracks and predicts menstrual cycles.
2015London, England, United KingdomUSD 269 MUSD 275.25 M701
Smartphone-enabled glucometers and diabetes management apps are provided.
2015Delhi, Delhi, IndiaUSD 50.83 MUSD 2.74 M142
Provider of a fertility tracking app that doubles as birth control
2013Stockholm, SwedenUSD 99.5 M––
Diabetes management is enabled via glucose meters and mobile apps.
2010Palo Alto, California, United StatesUSD 201 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Renalis

Renalis Raises $824K in Seed Funding
Finsmes β€’ 5 years ago
Premium access

Complete news archive for Renalis

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renalis

Renalis was founded in 2019.

Renalis is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Missy Lavender is the current CEO of Renalis. They have also founded this company.

Renalis is a funded company, having raised a total of $944K across 7 funding rounds to date. The company's 1st funding round was a Grant of $231.37K, raised on Sep 2019.

Renalis was founded in 2019 and is based in Chicago, United States. A platform is operated to deliver solutions in the pelvic health sector, focusing on management of related conditions. Experiences and outcomes for affected individuals are improved through targeted tools and approaches. Key challenges in pelvic health care, such as diagnosis and treatment efficiency, are addressed across operations.

Renalis's top competitors include Keleya, Every Mother and Liv Labs.

Renalis has made 1 acquisition, including Vesica.

Renalis has 5 investors. Key investors include HHS, Gener8tor, JumpStart Ventures, Collab Fund, and Village Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available